ONCOMETHYLOME Sciences (OMS) today announced the closing of a € 15 million Series B financing round led by Edmond de Rothschild Investment Partners, Paris, France. Existing investors ING Belgium, Life Sciences Partners, PolyTechnos Venture-Partners, Meusinvest and Technowal also participated in the round. Raphael Wisniewski of Edmond de Rothschild Investment Partners will join OMS´ Board of Directors.
